NCT00332787View on ClinicalTrials.gov

Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

October 31, 2005

Conditions
Depression
Interventions
DRUG

Fluoxetine

Trial Locations (1)

75235

Children's Medical Center at Dallas, Outpatient Psychiatry Clinic, Dallas

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT00332787 - Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents | Biotech Hunter | Biotech Hunter